Safety and Efficacy Study of ULTRASE® MT20 in Participants With Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (PI)

Clinical trial NCT00408317 · COMPLETED

Trial details

NCT number: NCT00408317
Sponsor: Forest Laboratories
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cystic Fibrosis Exocrine Pancreatic Insufficiency

Start date: 2006-11-01
Primary completion: 2007-04-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.